NANCY S REAU
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology BURR RIDGE, IL NPI 1164585683
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology IL Novo Nordisk AS All categories
General Payments — all program years on this page
$422,356.37
- Category: General Payments
- Program years: PY2018–2024
- Record count: 565
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $47,944.20 across 66 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $38,922.50 | 9 |
| Travel and Lodging | $4,730.69 | 13 |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,625.00 | 2 |
| Food and Beverage | $1,657.11 | 41 |
| Education | $8.90 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $26,011.14 | 13 |
| Gilead Sciences, Inc. | $13,590.44 | 25 |
| Abbott Laboratories | $2,984.02 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,647.36 | 5 |
| Mallinckrodt Hospital Products Inc. | $2,120.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $161.72 | 1 |
| Madrigal Pharmaceuticals | $156.68 | 4 |
| INTERCEPT PHARMACEUTICALS, INC. | $68.08 | 4 |
| ABBVIE INC. | $62.00 | 2 |
| Janssen Biotech, Inc. | $47.54 | 3 |
| Ardelyx, Inc. | $28.74 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.74 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.34 | 1 |
| Mirum Pharmaceuticals, Inc. | $13.91 | 1 |
| ALBIREO PHARMA, INC. | $13.49 | 1 |
By program year
Records — PY2024 (66)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.